Nucleosides and Analogues
Genscript Corporation CA15-3 AntibodyA5D8 mAb Mo
CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen It is a membrane-anchored mucin-type glycoprotein present in malignant cells It is used as tumor marker to monitor breast cancer treatment and disease recurrence
Genscript Corporation CA15-3 AntibodyA5D8 mAb Mo
CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen It is a membrane-anchored mucin-type glycoprotein present in malignant cells It is used as tumor marker to monitor breast cancer treatment and disease recurrence
Genscript Corporation CA15-3 AntibodyA5D8 mAb Mo
CA15-3 (Carcinoma antigen 15-3) is also known as MUC 1 antigen It is a membrane-anchored mucin-type glycoprotein present in malignant cells It is used as tumor marker to monitor breast cancer treatment and disease recurrence
Cayman Chemical 3-DeoxyurIdIn 100mg
A dehydroxylated derivative of uridine; inhibits uridine phosphorylase isolated from T. gondii (apparent Ki = 2.459 mM); decreases the proliferation of CCRF CEM, L1210, P388, and S180 cancer cells (EC50s = 25, 5, 2.5, and 15 µM, respectively); reduces the infection rate and number of T. cruzi amastigotes in HeLa cells at 1 µM; induces sodium currents in X. laevis oocytes expressing human CNT 1 or CNT 3 at 500 µM
Medchemexpress LLC 3'-Deoxycytidine | 7057-33-2 | 98.0% | 227.22 | 10 MG
3'-Deoxycytidine is a purine nucleoside analogue (4-Amino-1-((2R,3R,5S)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one) with broad antitumor activity against indolent lymphoid malignancies. Its anticancer mechanisms involve inhibition of DNA synthesis and induction of apoptosis.
- Inhibits replication of S180 cell line in vitro with an ED50 of 15 μM.
- Inhibits replication of CCRF-CEM cell line in vitro with an ED50 of 25 μM.
- Inhibits replication of L1210 cell line in vitro with an ED50 of 5 μM.
- Inhibits replication of P388 cell line in vitro with an ED50 of 2.5 μM.